Invasive breast cancer reporting guidelines: ICCR, CAP, RCPath, RCPA datasets and future directions

Diagnostic Histopathology Pub Date : 2024-02-01 DOI:10.1016/j.mpdhp.2023.11.001

Natthawadee Laokulrath, Mihir Ananta Gudi, Rahul Deb, Ian O Ellis, Puay Hoon Tan

{"title":"Invasive breast cancer reporting guidelines: ICCR, CAP, RCPath, RCPA datasets and future directions","authors":"Natthawadee Laokulrath, Mihir Ananta Gudi, Rahul Deb, Ian O Ellis, Puay Hoon Tan","doi":"10.1016/j.mpdhp.2023.11.001","DOIUrl":null,"url":null,"abstract":"<div><p>Pathological characteristics are essential for breast cancer staging and treatment; hence, regional and country-based pathology reporting protocols have been produced to facilitate comprehensive reporting by pathologists<span>. However, these guidelines can vary in reporting variables, terminology definition, methods of measurement/scoring, which may lead to discordant information for clinicians and disagreement among pathologists. To obviate this, the International Collaboration on Cancer Reporting (ICCR) has recently produced datasets for histological reporting of breast cancer to unify the reporting elements, facilitating international comparability. In this review, we focus on the invasive breast carcinoma reporting datasets with the aim of providing an overview of ICCR recommendations in comparison with those published by regional professional organizations (the Royal College of Pathologists of the United Kingdom (UK) (RCPath), the United States (US) College of American Pathologists (CAP), the Royal College of Pathologists of Australasia (RCPA)), including relevant evidence with practical tips on accurate reporting of breast cancer resection specimens. In addition, we discuss some divergent aspects and suggest future directions for a unified breast cancer pathology reporting framework.</span></p></div>","PeriodicalId":39961,"journal":{"name":"Diagnostic Histopathology","volume":"30 2","pages":"Pages 87-99"},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diagnostic Histopathology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1756231723001822","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Pathological characteristics are essential for breast cancer staging and treatment; hence, regional and country-based pathology reporting protocols have been produced to facilitate comprehensive reporting by pathologists. However, these guidelines can vary in reporting variables, terminology definition, methods of measurement/scoring, which may lead to discordant information for clinicians and disagreement among pathologists. To obviate this, the International Collaboration on Cancer Reporting (ICCR) has recently produced datasets for histological reporting of breast cancer to unify the reporting elements, facilitating international comparability. In this review, we focus on the invasive breast carcinoma reporting datasets with the aim of providing an overview of ICCR recommendations in comparison with those published by regional professional organizations (the Royal College of Pathologists of the United Kingdom (UK) (RCPath), the United States (US) College of American Pathologists (CAP), the Royal College of Pathologists of Australasia (RCPA)), including relevant evidence with practical tips on accurate reporting of breast cancer resection specimens. In addition, we discuss some divergent aspects and suggest future directions for a unified breast cancer pathology reporting framework.

查看原文本刊更多论文

浸润性乳腺癌报告指南：ICCR、CAP、RCPath、RCPA 数据集和未来方向

病理特征对于乳腺癌的分期和治疗至关重要；因此，以地区和国家为基础的病理报告规程已经制定出来，以方便病理学家进行全面报告。然而，这些指南在报告变量、术语定义、测量/评分方法等方面存在差异，可能导致临床医生获得的信息不一致，病理学家之间也会产生分歧。为了避免这种情况，国际癌症报告合作组织（ICCR）最近制作了乳腺癌组织学报告数据集，以统一报告要素，促进国际间的可比性。在本综述中，我们将重点放在浸润性乳腺癌报告数据集上，目的是概述 ICCR 建议与地区性专业组织（英国皇家病理学家学院 (RCPath)、美国病理学家学院 (CAP)、澳大拉西亚皇家病理学家学院 (RCPA)）发布的建议的比较，包括准确报告乳腺癌切除标本的相关证据和实用技巧。此外，我们还讨论了一些分歧，并提出了统一乳腺癌病理报告框架的未来发展方向。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diagnostic Histopathology Medicine-Pathology and Forensic Medicine

CiteScore

1.30

自引率

0.00%

发文量

期刊介绍： This monthly review journal aims to provide the practising diagnostic pathologist and trainee pathologist with up-to-date reviews on histopathology and cytology and related technical advances. Each issue contains invited articles on a variety of topics from experts in the field and includes a mini-symposium exploring one subject in greater depth. Articles consist of system-based, disease-based reviews and advances in technology. They update the readers on day-to-day diagnostic work and keep them informed of important new developments. An additional feature is the short section devoted to hypotheses; these have been refereed. There is also a correspondence section.